Dr. Yaacov Anziska, M.D

Neurology Brooklyn, NY Male
NPI: 1821161258
Total Payments
$26,133
2024 Payments
$2,760
Companies
27
Transactions
60
Medicare Patients
310
Medicare Billing
$39,907

Payment Breakdown by Category

Consulting$23,952 (91.7%)
Food & Beverage$1,598 (6.1%)
Other$515.00 (2.0%)
Education$67.48 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $23,952 23 91.7%
Food and Beverage $1,598 32 6.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $515.00 2 2.0%
Education $67.48 3 0.3%

Top Paying Companies

Company Total Records Latest Year
GENZYME CORPORATION $4,777 3 $0 (2022)
Biogen, Inc. $3,444 6 $0 (2022)
VERTEX PHARMACEUTICALS INCORPORATED $3,093 9 $0 (2024)
Alexion Pharmaceuticals, Inc. $2,734 6 $0 (2024)
CATALYST PHARMACEUTICALS, INC. $2,500 2 $0 (2020)
Amgen Inc. $2,200 1 $0 (2024)
ARGENX US, INC. $1,188 1 $0 (2023)
PTC Therapeutics, Inc. $1,171 2 $0 (2022)
Takeda Pharmaceuticals U.S.A., Inc. $1,100 1 $0 (2023)
UCB, Inc. $1,013 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,760 7 Amgen Inc. ($2,200)
2023 $2,467 4 ARGENX US, INC. ($1,188)
2022 $10,884 12 GENZYME CORPORATION ($4,757)
2021 $986.23 4 Vertex Pharmaceuticals Incorporated ($973.33)
2020 $6,643 7 Biogen, Inc. ($3,150)
2019 $1,073 4 VERTEX PHARMACEUTICALS INCORPORATED ($580.00)
2018 $980.15 17 VERTEX PHARMACEUTICALS INCORPORATED ($373.33)
2017 $339.53 5 F. Hoffmann-La Roche AG ($282.00)

All Payment Transactions

60 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
11/26/2024 Amgen Inc. UPLIZNA (Biological) Consulting Fee Cash or cash equivalent $2,200.00 General
Category: Inflammation/Rare Disease
11/18/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $30.19 General
Category: Rare Disease
11/04/2024 VERTEX PHARMACEUTICALS INCORPORATED — Consulting Fee Cash or cash equivalent $360.00 General
09/02/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $27.37 General
Category: Rare Disease
07/15/2024 ITF Therapeutics LLC — Food and Beverage In-kind items and services $26.28 General
03/05/2024 Genentech USA, Inc. Evrysdi (Drug) Food and Beverage In-kind items and services $98.81 General
Category: Neurology
02/27/2024 Amylyx Pharmaceuticals, Inc. RELYVRIO (Drug) Food and Beverage In-kind items and services $17.19 General
Category: NEUROLOGY
12/14/2023 ARGENX US, INC. VYVGART (Drug) Consulting Fee Cash or cash equivalent $1,188.00 General
Category: Immunology
12/01/2023 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $1,100.00 General
04/27/2023 AbbVie Inc. BOTOX (Biological) Food and Beverage In-kind items and services $150.00 General
Category: NEUROSCIENCE
04/21/2023 AbbVie Inc. BOTOX (Biological) Food and Beverage In-kind items and services $29.38 General
Category: BOTOX THERAPEUTIC
12/23/2022 BeiGene USA, Inc. BRUKINSA (Drug) Consulting Fee Cash or cash equivalent $320.00 General
Category: Oncology
11/09/2022 Sarepta Therapeutics, Inc. — Consulting Fee Cash or cash equivalent $325.00 General
08/02/2022 PTC Therapeutics, Inc. EMFLAZA (Drug) Food and Beverage In-kind items and services $61.07 General
Category: DMD
07/01/2022 Vertex Pharmaceuticals Incorporated — Consulting Fee Cash or cash equivalent $413.33 General
06/28/2022 Alexion Pharmaceuticals, Inc. — Consulting Fee Cash or cash equivalent $2,626.50 General
06/01/2022 GENZYME CORPORATION LUMIZYME (Biological) Consulting Fee Cash or cash equivalent $4,672.00 General
Category: Genetic Disease
05/18/2022 PTC Therapeutics, Inc. EMFLAZA (Drug) Consulting Fee Cash or cash equivalent $1,110.00 General
Category: DMD
03/23/2022 UCB, Inc. — Consulting Fee Cash or cash equivalent $1,012.50 General
03/15/2022 GENZYME CORPORATION — Food and Beverage In-kind items and services $84.71 General
03/14/2022 Biogen, Inc. SPINRAZA (Biological) Food and Beverage In-kind items and services $108.98 General
Category: Neurology
03/14/2022 Sarepta Therapeutics, Inc. — Food and Beverage In-kind items and services $75.00 General
01/07/2022 Novartis Gene Therapies, Inc. (fka AveXis, Inc.) — Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $75.00 General
11/10/2021 Vertex Pharmaceuticals Incorporated — Consulting Fee Cash or cash equivalent $293.33 General
09/30/2021 Janssen Pharmaceuticals, Inc — Food and Beverage In-kind items and services $12.90 General
123»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 92 108 $38,295 $9,823
2022 4 52 105 $33,963 $9,022
2021 5 80 109 $38,633 $10,736
2020 5 86 113 $41,270 $10,327
Total Patients
310
Total Services
435
Medicare Billing
$39,907
Procedure Codes
18

All Medicare Procedures & Services

18 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 27 33 $12,606 $3,097 24.6%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 22 24 $12,072 $2,870 23.8%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 23 30 $8,115 $2,095 25.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 20 21 $5,502 $1,760 32.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 15 29 $11,078 $3,382 30.5%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 12 46 $12,374 $3,116 25.2%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 11 11 $5,533 $1,289 23.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 14 19 $4,978 $1,234 24.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 23 31 $8,122 $2,454 30.2%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 15 15 $8,730 $2,322 26.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 13 20 $7,640 $2,315 30.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 18 32 $8,608 $2,201 25.6%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 11 11 $5,533 $1,444 26.1%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 21 41 $11,029 $2,804 25.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 20 26 $9,932 $2,377 23.9%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 17 17 $8,551 $2,249 26.3%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 13 13 $7,566 $1,874 24.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 15 16 $4,192 $1,023 24.4%

About Dr. Yaacov Anziska, M.D

Dr. Yaacov Anziska, M.D is a Neurology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821161258.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yaacov Anziska, M.D has received a total of $26,133 in payments from pharmaceutical and medical device companies, with $2,760 received in 2024. These payments were reported across 60 transactions from 27 companies. The most common payment nature is "Consulting Fee" ($23,952).

As a Medicare-enrolled provider, Anziska has provided services to 310 Medicare beneficiaries, totaling 435 services with total Medicare billing of $39,907. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Brooklyn, NY
  • Active Since 11/15/2006
  • Last Updated 02/16/2024
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1821161258

Products in Payments

  • LUMIZYME (Biological) $4,672
  • FIRDAPSE (Drug) $2,500
  • UPLIZNA (Biological) $2,200
  • VYVGART (Drug) $1,188
  • EMFLAZA (Drug) $1,171
  • EXPAREL (Drug) $440.00
  • BRUKINSA (Drug) $320.00
  • SPINRAZA (Biological) $293.60
  • EXONDYS 51 (Drug) $230.99
  • BOTOX (Biological) $179.38
  • Exondys 51 (Drug) $133.27
  • GAMMAGARD LIQUID (Biological) $120.01
  • Evrysdi (Drug) $98.81
  • Gamunex-C (Biological) $93.68
  • ULTOMIRIS (Biological) $57.56
  • SOLIRIS (Drug) $49.57
  • KEVEYIS (Drug) $40.61
  • Radicava (Drug) $25.48
  • RYTARY (Drug) $24.05
  • BOTOX - NEUROLOGY (Drug) $21.21

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Brooklyn

Karen Blitz-Shabbir, Do, DO

Neurology — Payments: $393,441

Neurology $393,441

Miss. Larisa Syrow, Md, MD

Neurology — Payments: $182,526

Neurology $182,526

Nada Abou-Fayssal, Md, MD

Neurology — Payments: $126,065

Neurology $126,065

Robyn Wolintz, Md, MD

Neurology — Payments: $123,772

Neurology $123,772

Miran Salgado, Md, MD

Neurology — Payments: $101,072

Neurology $101,072

Dr. Dmitriy Grinshpun, M.d, M.D

Neurology — Payments: $96,680

Neurology $96,680